PP
OLMA icon

PDT Partners’s Olema Pharmaceuticals OLMA Stock Holding History

PDT Partners’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$228K Sell
15,301
-12,067
-44% -$269K 0.01% 486
2025
Q4 		$684K Buy
27,368
+12,067
+79% +$215K 0.04% 381
2025
Q3 		$150K Sell
15,301
-13,036
-46% -$78.3K 0.01% 557
2025
Q2 		$121K Sell
28,337
-45,962
-62% -$205K 0.01% 664
2025
Q1 		$279K Buy
+74,299
New +$374K 0.02% 624
2023
Q2 		– Sell
-10,573
Closed -$36.7K – 633
2023
Q1 		$36.7K Sell
10,573
-12,841
-55% -$52.4K 0.01% 555
2022
Q4 		$57.4K Sell
23,414
-13,127
-36% -$38.3K 0.01% 599
2022
Q3 		$101K Sell
36,541
-55,813
-60% -$237K 0.02% 780
2022
Q2 		$376K Sell
92,354
-30,004
-25% -$95.2K 0.03% 685
2022
Q1 		$521K Buy
122,358
+97,189
+386% +$536K 0.04% 572
2021
Q4 		$236K Buy
+25,169
New +$521K 0.02% 735

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

PDT Partners's OLMA Position: Q1 2026 in Review

PDT Partners reduced its Olema Pharmaceuticals (OLMA) stake by 44% in Q1 2026, selling an estimated $269K and leaving 15,301 shares worth $228K. The position accounts for 0.01% of the portfolio, ranked #486.

PDT Partners first reported a position in OLMA in Q4 2021 and has held it in 11 quarters since. The position peaked at $684K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • PDT Partners held 15,301 shares of Olema Pharmaceuticals worth $228K as of Q1 2026.
  • PDT Partners sold 12,067 Olema Pharmaceuticals shares in Q1 2026, an estimated $269K.
  • Olema Pharmaceuticals made up 0.01% of PDT Partners's portfolio in Q1 2026, its #486 holding.
  • PDT Partners first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 11 quarters since.
  • PDT Partners's Olema Pharmaceuticals position peaked at $684K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.